Then they mapped single-cell lineage output to gene expression against a cDNA library to generate a molecular ... “The results tell us that there’s some sort of mechanism or quantitative association ...

Broadwood Partners, L.P., a significant stakeholder in Lineage Cell Therapeutics, Inc. (NYSE:LCTX), has acquired a substantial amount of the company's common shares. The acquisition, valued at $6 ...

Historically, cell lineage tracing studies have taken large pools of cells from mature tissues and inferred their origins retrospectively by staining the cells with vital dyes or transplanting ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) had its price objective decreased by Maxim Group from $5.00 to $3.00 in a research report sent to investors on Friday morning ...